These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
534 related items for PubMed ID: 22574694
21. [Prognostic and stratified value of adrenomedullin in community acquired pneumonia patients in emergency department]. Chen Y, Li C. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 Feb; 26(2):115-9. PubMed ID: 24524403 [Abstract] [Full Text] [Related]
24. External validation of the CURSI criteria (confusion, urea, respiratory rate and shock index) in adults hospitalised for community-acquired pneumonia. Nüllmann H, Pflug MA, Wesemann T, Heppner HJ, Pientka L, Thiem U. BMC Infect Dis; 2014 Jan 22; 14():39. PubMed ID: 24447823 [Abstract] [Full Text] [Related]
25. Mortality prediction in community-acquired pneumonia requiring mechanical ventilation; values of pneumonia and intensive care unit severity scores. Aydoğdu M, Ozyilmaz E, Aksoy H, Gürsel G, Ekim N. Tuberk Toraks; 2010 Jan 22; 58(1):25-34. PubMed ID: 20517726 [Abstract] [Full Text] [Related]
27. Pneumonia Severity Index and CURB-65 Score Are Good Predictors of Mortality in Hospitalized Patients With SARS-CoV-2 Community-Acquired Pneumonia. Bradley J, Sbaih N, Chandler TR, Furmanek S, Ramirez JA, Cavallazzi R. Chest; 2022 Apr 22; 161(4):927-936. PubMed ID: 34740594 [Abstract] [Full Text] [Related]
31. Community-acquired pneumonia in older patients: does age influence systemic cytokine levels in community-acquired pneumonia? Kelly E, MacRedmond RE, Cullen G, Greene CM, McElvaney NG, O'Neill SJ. Respirology; 2009 Mar 22; 14(2):210-6. PubMed ID: 19272082 [Abstract] [Full Text] [Related]
32. Prognostic value of procalcitonin in community-acquired pneumonia. Schuetz P, Suter-Widmer I, Chaudri A, Christ-Crain M, Zimmerli W, Mueller B, Procalcitonin-Guided Antibiotic Therapy and Hospitalisation in Patients with Lower Respiratory Tract Infections (ProHOSP) Study Group. Eur Respir J; 2011 Feb 22; 37(2):384-92. PubMed ID: 20595156 [Abstract] [Full Text] [Related]
33. [Prognostic factors and mortality in immunocompetent adult patients hospitalized with community-acquired pneumococcal pneumonia]. Saldías P F, Viviani G P, Pulgar B D, Valenzuela F F, Paredes E S, Díaz P O. Rev Med Chil; 2009 Dec 22; 137(12):1545-52. PubMed ID: 20361129 [Abstract] [Full Text] [Related]
35. Predictive accuracy of the pneumonia severity index vs CRB-65 for time to clinical stability: results from the Community-Acquired Pneumonia Organization (CAPO) International Cohort Study. Arnold FW, Brock GN, Peyrani P, Rodríguez EL, Díaz AA, Rossi P, Ramirez JA, CAPO authors. Respir Med; 2010 Nov 22; 104(11):1736-43. PubMed ID: 20576417 [Abstract] [Full Text] [Related]
39. Risk factors for complicated parapneumonic effusion and empyema on presentation to hospital with community-acquired pneumonia. Chalmers JD, Singanayagam A, Murray MP, Scally C, Fawzi A, Hill AT. Thorax; 2009 Jul 22; 64(7):592-7. PubMed ID: 19131449 [Abstract] [Full Text] [Related]
40. Mortality prediction to hospitalized patients with influenza pneumonia: PO2 /FiO2 combined lymphocyte count is the answer. Shi SJ, Li H, Liu M, Liu YM, Zhou F, Liu B, Qu JX, Cao B. Clin Respir J; 2017 May 22; 11(3):352-360. PubMed ID: 26148709 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]